Organic Letters
Letter
AUTHOR INFORMATION
■
Corresponding Author
ORCID
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
We thank Prof. Dr. Yu-Rong Yang (Kunming Institute of
Botany) for suggestions and discussions. We are grateful for the
financial support from the Hundred Talents Program of the
Chinese Academy of Sciences, the Program of Yunling
Scholarship, the West Light Foundation of CAS (Western
Youth Scholars “A”), the China Postdoctoral ScienceFounda-
tion (2015M580801), and the China Postdoctoral Science
Foundation−Chinese Academy of Sciences joint grant.
Figure 2. Structures of the chiral phosphoric acid compounds.
REFERENCES
■
(1) For a review, see: Ruan, J.; Zhao, Z.; Zeng, Q.; Qian, Z. Chin.
Pharm. Bull. 2003, 19, 965−970.
ee values reached 96% after a simple recrystallization from
acetone−hexane (1:4, v/v), and the synthetic sample had a
rotation of −320.3 (c 0.23, MeOH). In addition, 457 mg of
(+)-paeoveitol was synthesized with 89% ee using the
(2) (a) Xie, Z. L.; Wang, X. H. Chin. J. Inf. TCM 2005, 12, 8−9.
(b) Chang, H. S.; Liang, J. C.; Sun, J. N.; Wang, Q. G.; Li, J. J. Beijing
Univ. TCM 2006, 29, 451−453. (c) Bao, L.; Chen, J.; Huang, L.; Chen,
W.; Lin, Q.; Yao, X. S.; Hiroshi, K. J. Chin. Med. Mater. 2008, 31,
1360−1364. (d) Li, L.; Zhang, X.; Yan, T.; Li, Q.; Liu, S.; Wu, L.; Yan,
C.; Tan, H. Neural Regen. Res. 2010, 5, 1396−1402.
enantiomer of C9 as a chiral catalyst ([α]22 +272.4 (c 0.22,
D
MeOH)). A single crystal of 1b was obtained by recrystalliza-
tion from CH3OH; X-ray crystallographic analysis with copper
radiation unambiguously determined the configuration of the
three contiguous stereocenters as 7S,8S,9R (Figure 3).
(3) (a) Liang, W. J.; Geng, C. A.; Zhang, X. M.; Chen, H.; Yang, C.
Y.; Rong, G. Q.; Zhao, Y.; Xu, H.-B.; Wang, H.; Zhou, N. J.; Ma, Y.-B.;
Huang, X. Y.; Chen, J. J. Org. Lett. 2014, 16, 424−427. (b) Liang, W.
J.; Ma, Y. B.; Geng, C. A.; Huang, X. Y.; Xu, H. B.; Zhang, X. M.;
Chen, J. J. Fitoterapia 2015, 106, 36−40.
(4) For selected reviews, see: (a) Mori, K. Chirality 2011, 23, 449−
462. (b) Leffingwell, J. C. Leffingwell Rep. 2003, 3, 1−27.
(5) Xu, L.; Liu, F.; Xu, L.-W.; Gao, Z.; Zhao, Y.-M. Org. Lett. 2016,
18, 3698−3701.
(6) Zhang, Y.; Guo, Y.; Li, Z.; Xie, Z. Org. Lett. 2016, 18, 4578−4581.
(7) For reviews of o-QM, see: (a) Willis, N. J.; Bray, C. D. Chem. -
Eur. J. 2012, 18, 9160−9173. (b) Singh, M. S.; Nagaraju, A.; Anand,
N.; Chowdhury, S. RSC Adv. 2014, 4, 55924−55959. (c) Ai, W. Y.;
Liao, D. H.; Lei, X. G. Youji Huaxue 2015, 35, 1615−1626.
(8) Luan, Y.; Schaus, S. E. J. Am. Chem. Soc. 2012, 134, 19965−
19968.
Figure 3. X-ray crystal structure of 1b.
(9) (a) El-Sepelgy, O.; Haseloff, S.; Alamsetti, S. K.; Schneider, C.
Angew. Chem., Int. Ed. 2014, 53, 7923−7927. (b) Hsiao, C.-C.; Liao,
H.-H.; Rueping, M. Angew. Chem., Int. Ed. 2014, 53, 13258−13263.
(10) Chuang, K. V.; Navarro, R.; Reisman, S. E. Chem. Sci. 2011, 2,
1086−1089.
In summary, the enantioselective total synthesis of (+)- and
(−)-paeoveitol was completed in six steps and 42% overall
yield. The most significant tactical feature of this synthesis
involves the chiral acid-catalyzed asymmetric hetero-Diels−
Alder reaction, which enabled us to selectively synthesize both
paeoveitol enantiomers from the same substrates by simply
changing the catalyst’s stereochemistry. Efforts to expand the
application of this key transformation in the asymmetric total
synthesis of other benzopyran-containing natural products are
ongoing in our laboratory.
(11) Fugard, A. J.; Thompson, B. K.; Slawin, A. M. Z.; Taylor, J. E.;
Smith, A. D. Org. Lett. 2015, 17, 5824−5827.
(12) Kil’met’ev, A. S.; Shul’ts, E. E.; Shakirov, M. M.; Rybalova, T. V.;
Tolstikov, G. A. Russ. J. Org. Chem. 2013, 49, 872−885.
(13) Macías, F. A.; Chinchilla, D.; Molinillo, J. M. G.; Marín, D.;
Varela, R. M.; Torres, A. Tetrahedron 2003, 59, 1679−1683.
(14) Xing, C. H.; Liao, Y. X.; Ng, J.; Hu, Q. S. J. Org. Chem. 2011, 76,
4125−4131.
ASSOCIATED CONTENT
■
S
* Supporting Information
The Supporting Information is available free of charge on the
Experimental details of chemical synthesis, compound
X-ray crystallographic data for compound 1b (CIF)
C
Org. Lett. XXXX, XXX, XXX−XXX